AAOS2019: TXA vs. EACA vs. control on pain and function in an ACL reconstruction .
Evaluation of Antifibrinolytic Use in Anterior Cruciate Ligament Arthroscopic Reconstruction: A Randomized Prospective Clinical Trial
45 patients scheduled for anterior cruciate ligament reconstruction were randomized to receive tranexamic acid (TXA), epsilon aminocaproic acid (EACA) or no intervention. Outcomes of interest included pain on a visual analog scale, Lysholm score, knee range of motion, and degree of hemarthrosis. The results from this study found significantly favourable pain scores in the TXA group compared to the control group at 7 days. Furthermore, Lysholm scores were significantly favourable in the TXA group compared to both the EACA and control groups at 14 days. Otherwise, no significant differences were observed in the remaining outcomes.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
